Exploring Teclistamab’s Potential in Combination Therapy for Multiple Myeloma: Marc S. Raab, MD, PhD
Marc S. Raab, MD, PhD, discusses the different ways that combination therapy that includes teclistamab can benefit patients with multiple myeloma.
Marc S. Raab, MD, PhD
Advertisement
Articles by Marc S. Raab, MD, PhD
The MajesTEC-5 trial shows teclistamab's impressive efficacy in achieving MRD-negative status in newly diagnosed transplant-eligible patients, explains Marc S. Raab, MD, PhD.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
2
Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment
3
POLY-HF: Polypill Boosts Heart Function, Adherence in Heart Failure
4
Bridging the Gap Between Cutting-Edge Cancer Care and Equitable Access
5
